Alkyl Amines Chemicals Limited (BOM: 506767)
India
· Delayed Price · Currency is INR 1,953.55
+19.65 (1.02%)
At close: Nov 14, 2024
Alkyl Amines Chemicals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 14,932 | 14,406 | 16,831 | 15,420 | 12,424 | 9,929 | Upgrade
|
| Revenue Growth (YoY) | -4.42% | -14.41% | 9.15% | 24.11% | 25.13% | 17.31% | Upgrade
|
| Cost of Revenue | 8,066 | 7,862 | 8,791 | 8,500 | 5,340 | 4,956 | Upgrade
|
| Gross Profit | 6,867 | 6,544 | 8,040 | 6,920 | 7,085 | 4,973 | Upgrade
|
| Selling, General & Admin | 998.35 | 954.25 | 977.49 | 883.33 | 929.65 | 701.11 | Upgrade
|
| Other Operating Expenses | 3,009 | 3,034 | 3,575 | 2,768 | 1,852 | 1,686 | Upgrade
|
| Operating Expenses | 4,706 | 4,578 | 5,004 | 3,999 | 3,072 | 2,656 | Upgrade
|
| Operating Income | 2,160 | 1,967 | 3,036 | 2,921 | 4,012 | 2,317 | Upgrade
|
| Interest Expense | -19.74 | -39.74 | -27.3 | -25.27 | -47.66 | -88.66 | Upgrade
|
| Interest & Investment Income | 9.04 | 9.04 | 10.29 | 41.68 | 26.62 | 23.91 | Upgrade
|
| Currency Exchange Gain (Loss) | 119.87 | 119.87 | 109.25 | 84.25 | 28.58 | 19.74 | Upgrade
|
| Other Non Operating Income (Expenses) | 57 | -3.5 | -3.23 | -6.9 | -13.65 | -13.11 | Upgrade
|
| EBT Excluding Unusual Items | 2,326 | 2,052 | 3,125 | 3,015 | 4,006 | 2,259 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | 14.81 | 2.44 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -11.44 | -11.44 | -39.85 | -8.64 | -11.64 | -4.03 | Upgrade
|
| Asset Writedown | -26.03 | -26.03 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 328.42 | Upgrade
|
| Pretax Income | 2,299 | 2,025 | 3,086 | 3,021 | 4,007 | 2,597 | Upgrade
|
| Income Tax Expense | 616.95 | 535.95 | 799.03 | 772.18 | 1,054 | 444.28 | Upgrade
|
| Net Income | 1,682 | 1,489 | 2,287 | 2,249 | 2,953 | 2,153 | Upgrade
|
| Net Income to Common | 1,682 | 1,489 | 2,287 | 2,249 | 2,953 | 2,153 | Upgrade
|
| Net Income Growth | -1.86% | -34.89% | 1.67% | -23.85% | 37.19% | 150.02% | Upgrade
|
| Shares Outstanding (Basic) | 51 | 51 | 51 | 51 | 51 | 51 | Upgrade
|
| Shares Outstanding (Diluted) | 51 | 51 | 51 | 51 | 51 | 51 | Upgrade
|
| Shares Change (YoY) | 0.03% | 0.01% | 0.02% | 0.05% | 0.03% | - | Upgrade
|
| EPS (Basic) | 32.90 | 29.13 | 44.75 | 44.04 | 57.90 | 42.22 | Upgrade
|
| EPS (Diluted) | 32.86 | 29.09 | 44.68 | 43.95 | 57.75 | 42.11 | Upgrade
|
| EPS Growth | -1.88% | -34.89% | 1.66% | -23.90% | 37.15% | 150.05% | Upgrade
|
| Free Cash Flow | 2,592 | 1,527 | -550.43 | -422.75 | 2,078 | 1,113 | Upgrade
|
| Free Cash Flow Per Share | 50.63 | 29.83 | -10.76 | -8.26 | 40.64 | 21.77 | Upgrade
|
| Dividend Per Share | - | 10.000 | 10.000 | 10.000 | 10.000 | 8.000 | Upgrade
|
| Dividend Growth | - | 0% | 0% | 0% | 25.00% | 150.00% | Upgrade
|
| Gross Margin | 45.98% | 45.43% | 47.77% | 44.88% | 57.02% | 50.08% | Upgrade
|
| Operating Margin | 14.47% | 13.65% | 18.04% | 18.94% | 32.29% | 23.34% | Upgrade
|
| Profit Margin | 11.26% | 10.33% | 13.59% | 14.58% | 23.77% | 21.68% | Upgrade
|
| Free Cash Flow Margin | 17.36% | 10.60% | -3.27% | -2.74% | 16.73% | 11.21% | Upgrade
|
| EBITDA | 2,850 | 2,547 | 3,480 | 3,265 | 4,299 | 2,581 | Upgrade
|
| EBITDA Margin | 19.09% | 17.68% | 20.68% | 21.17% | 34.60% | 26.00% | Upgrade
|
| D&A For EBITDA | 689.94 | 580.04 | 444.26 | 343.63 | 286.82 | 264.47 | Upgrade
|
| EBIT | 2,160 | 1,967 | 3,036 | 2,921 | 4,012 | 2,317 | Upgrade
|
| EBIT Margin | 14.47% | 13.65% | 18.04% | 18.94% | 32.29% | 23.34% | Upgrade
|
| Effective Tax Rate | 26.84% | 26.47% | 25.90% | 25.56% | 26.29% | 17.11% | Upgrade
|
| Revenue as Reported | 15,143 | 14,557 | 16,962 | 15,570 | 12,494 | 9,999 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.